Andersons vs Ingredion
ANDE and INGR side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ANDE and INGR compare
Ingredion is the larger company, worth 3.2 times as much as Andersons ($5.9B against $1.9B).
On earnings, Andersons is cheaper: it trades at 9.3× trailing earnings, against 10.7× for Ingredion.
Ingredion grew revenue faster over the last twelve months (−0.98% versus −4.3% for Andersons).
Ingredion keeps more of each dollar of sales as profit, with a net margin of 7.8% compared with 1.8% at Andersons.
Both pay dividends: Andersons yields 1.4% and Ingredion 3.5%.
Ingredion scores higher on the StockData Score (20 against 17 for Andersons), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ANDE | INGR |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $5.9B |
| Share price | $55.40 | $94.14 |
| Change, 1 year | 11.2% | −13.0% |
| Change, 5 years | 51.5% | −2.8% |
| Beta (5Y) | 0.51 | 0.41 |
| Employees | 2,137 | 11K |
| StockData Score | ||
| Total score | 17 | 20 (better) |
| Valuation score | 5 | 6 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 4 | 5 (better) |
| Health score | 3 | 5 (better) |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 9.3× (better) | 10.7× |
| P/S | 0.2× (better) | 0.8× |
| P/B | 1.4× | 1.3× (better) |
| EV/EBITDA | – | 6.5× |
| P/FCF | – | 17.1× |
| PEG | – | 0.71 |
| FCF yield | −15.6% | 5.8% (better) |
| Fair value | $107.78 | $161.40 |
| Margin of safety | 48.6% (better) | 41.7% |
| Growth | ||
| Revenue growth (TTM) | −4.3% | −0.98% (better) |
| Revenue growth, 5Y average | 6.4% (better) | 3.8% |
| Net income growth (TTM) | 178% (better) | −14.6% |
| EPS growth (TTM) | 177% (better) | −12.4% |
| EPS growth, 5Y average | – | 16.8% |
| Profitability | ||
| Gross margin | 7.2% | 23.0% (better) |
| Operating margin | – | 11.3% |
| Net margin | 1.8% | 7.8% (better) |
| FCF margin | −2.6% | 4.8% (better) |
| Return on equity | 16.1% (better) | 12.8% |
| Return on invested capital | – | 11.5% |
| Financial health | ||
| Debt / equity | 0.80 | 0.39 (better) |
| Net debt / EBITDA | – | 0.76 |
| Current ratio | 1.43 | 2.01 (better) |
| Altman Z-score | 4.05 (better) | 3.50 |
| Piotroski F-score | 4 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.4% | 3.5% (better) |
| Payout ratio | 13.4% | 37.7% |
| Years of dividend growth | 16 | – |
| Dividend growth, 5Y average | 2.3% | – |
| Shareholder yield | 1.4% | 3.5% (better) |
| Ownership | ||
| Held by institutions | 89.7% | 98.9% |
| Held by insiders | 4.3% | 0.83% |
| Insider net buying, 12 months | −$9.8M | −$6.0M (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 4.3% | 7.3% |
Go deeper
- ANDE stock overview
- ANDE income statement
- ANDE valuation and score
- INGR stock overview
- INGR income statement
- INGR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.